The Brazilian Serialization Initiative
Brazil, home of 191M people and the largest drug market in South America (estimated at $17B in 2008), has just implemented a three-year plan to track all of its medicinal
Governments and Anti-Counterfeit Companies Respond to Increased Counterfeiting
Although Sproxil’s authentication technology is currently being used only in the pharmaceutical industry, we are in discussions to apply it to other industries as well. You can immediately understand why
WHO highlights INTERPOL’s work on confiscating fake products
As the WHO makes progress on the definition of counterfeit drugs and medical devices, we find it interesting that it is collaborating with INTERPOL to highlight the need for good
Market research shows emerging market mobile advertising growing rapidly
JBB Research, a leading market analysis company in the mobile space, just released its newsletter on mobile advertising in international markets. As our MPATM technology provides brand owners and marketers
Partnership for Safe Meds commends NAFDAC for adopting SMS technology
In the most recent Partnership for Safe Medicines (PSM) newsletter update, we note that the article features NAFDAC’s use of our MPATM technology in their new, free-to-consumer Mobile Authentication Service
Mobile Phone Experts weigh in on Sproxil’s technology
Reuters recently asked experts in the mobile phone industry to weigh in on Sproxil’s technology. This follow-up piece on the original article gives readers some interesting feedback on our MPATM
Anti-Counterfeit Collaboration to Combat Counterfeiting
The counterfeit issue has become so widespread in the Nigerian marketplace that non-governmental organizations and major brands alike have turned to the government for help. The Anti-Counterfeit Collaboration (ACC) was
Reuters: Mobile startup takes on drug counterfeiters
Reuters just featured Sproxil’s progress on securing valuable brands and keeping consumers safe from counterfeits. The detailed article comes complete with a Sproxil factbox, video interview with our CFO and
Recent media coverage
Today has been an extremely busy day at the Sproxil offices. In addition to the piece in the Wall Street Journal we also got coverage by Venture Capital Dispatch and
Studies show alarming prevalence of sub-standard medication in Africa
Only months after the The US Pharmacopoea (USP) assisted in the discovery of fake antimalarials in Ghana, a West-African nation, major studies are now beginning to reveal the true depth